Shenzhen Weiguang Biological Equity Investment Management Co., Ltd. announced that it will receive CNY 40,000,000 in an equity round of funding from returning investor Shenzhen Weiguang Biological Products Co.,Ltd (SZSE:002880) on April 11, 2019. On closing, the investor retains its 100% stake in the company. Post-closing, the registered capital of the company will increase from CNY 10,000,000 to CNY 500,000,000. The transaction was approved by the board of directors of the investor in its 2nd directorate’s 21th meeting.